ריספרדל קונסטה 37.5 מג इसराइल - हिब्रू - Ministry of Health

ריספרדל קונסטה 37.5 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 37.5 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 37.5 מג इसराइल - हिब्रू - Ministry of Health

ריספרדל קונסטה 37.5 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 37.5 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 50 מג इसराइल - हिब्रू - Ministry of Health

ריספרדל קונסטה 50 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 50 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

ריספרדל קונסטה 50 מג इसराइल - हिब्रू - Ministry of Health

ריספרדל קונסטה 50 מג

j-c health care ltd - risperidone - אבקה לתרחיף להזרקה - risperidone 50 mg/vial - risperidone - risperidone - risperdal consta is indicated for the treatment of schizophrenia and schizoaffective disorders.risperdal consta is indicated as monotherapy for the maintenance treatment of bipolar i disorder to delay occurrence of mood episodes.risperdal consta is indicated for adjunctive maintenance treatment to delay occurrence of mood episodes in patients with frequently relapsing bipolar disorder.

סינופד טבליות इसराइल - हिब्रू - Ministry of Health

סינופד טבליות

trima israel pharmaceutical products maabarot ltd - pseudoephedrine hydrochloride - טבליה - pseudoephedrine hydrochloride 60 mg - pseudoephedrine - pseudoephedrine - symptomatic treatment of nasal congestion, to relieve eustachian tube congestion.

סינופד סירופ इसराइल - हिब्रू - Ministry of Health

סינופד סירופ

trima israel pharmaceutical products maabarot ltd - pseudoephedrine hydrochloride - סירופ - pseudoephedrine hydrochloride 30 mg / 5 ml - pseudoephedrine - pseudoephedrine - symptomatic treatment of nasal congestion, to relief eustachian tube congestion.

בודיקורט רספיולס 0.5 מג2 מל इसराइल - हिब्रू - Ministry of Health

בודיקורט רספיולס 0.5 מג2 מל

astrazeneca (israel) ltd - budesonide - תרחיף לשאיפה - budesonide 0.25 mg/ml - budesonide - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

בודיקורט רספיולס 1 מג2 מל इसराइल - हिब्रू - Ministry of Health

בודיקורט רספיולס 1 מג2 מל

astrazeneca (israel) ltd - budesonide - תרחיף לשאיפה - budesonide 0.5 mg/ml - budesonide - budesonide - bronchial asthma, especially in cases where other therapy is insufficient or unsuitable.

אטרובנט इसराइल - हिब्रू - Ministry of Health

אטרובנט

boehringer ingelheim israel ltd. - ipratropium bromide - משאף - ipratropium bromide 0.02 mg - ipratropium bromide - ipratropium bromide - for the relief of symptoms of reversible bronchospasm associated with asthma, chronic bronchitis and emphysema.

סירן 200 מג טבליות תוססות इसराइल - हिब्रू - Ministry of Health

סירן 200 מג טבליות תוססות

megapharm ltd - acetylcysteine - טבליה תוססת - acetylcysteine 200 mg - acetylcysteine - acetylcysteine - mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.